PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Search This Blog

Loading...

Wednesday, September 2, 2015

skoner, baxter travenol

custom search

REVERSED
Tech Center 1700 Chemical & Materials Engineering
1742 Ex Parte Etesse 12568205 - (D) WARREN 103 THE PROCTER & GAMBLE COMPANY HUSON, MONICA ANNE

Tech Center 2600 Communications
2649 Ex Parte Khitun et al 12049040 - (D) STRAUSS 103 Vista IP Law Group LLP SHERIF, FATUMA G

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1627 Ex Parte Schiene et al 12879562 - (D) FREDMAN 103 CROWELL & MORING LLP KANTAMNENI, SHOBHA

"Expected beneficial results are evidence of obviousness of a claimed invention.  Just as unexpected beneficial results are evidence of unobviousness."  In re Skoner, 517 F.2d 947, 950 (CCPA 1975). ...

"[W]hen unexpected results are used as evidence of nonobviousness, the results must be shown to be unexpected compared with the closest prior art."  In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed.Cir. 1991).

Baxter Travenol Labs., In re, 952 F.2d 388, 21 USPQ2d 1281 (Fed. Cir. 1991) 2131.01 2145

No comments :